Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2019

23.09.2019 | Gynecologic Endocrinology and Reproductive Medicine

Oxidative stress indicators in Chinese women with PCOS and correlation with features of metabolic syndrome and dependency on lipid patterns

verfasst von: Husheng Wang, Xiangyan Ruan, Yanglu Li, Jiaojiao Cheng, Alfred O. Mueck

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim was to investigate oxidative stress indicators in the blood of women with PCOS without and with metabolic syndrome (MS) and their dependency on lipids, comparing with healthy women. To our knowledge, this is the first study on this topic.

Methods

This was a cross-sectional study, and blood tests performed were double-blind. Within 3 months, 205 PCOS patients, from whom 55 also had MS, and 65 healthy women (control) were recruited. Malondialdehyde (MDA) was assessed as an important oxidative indicator, and superoxide dismutase (SOD), total antioxidant activity (TAA), vitamin C (VC), vitamin E (VE) and retinol (RET) as antioxidative indicators. Their correlation with features of MS was analyzed including their dependency on lipid pattern.

Results

SOD, TAA, VE and RET in the PCOS group and PCOS + MS group were lower and MDA higher than in the control group (p < 0.05). SOD, VE and RET were the lowest in PCOS + MS group (p < 0.05). Thus, patients in this group had the highest oxidative stress levels but the lowest antioxidative capacity. SOD and TAA significantly decreased with increase of triglycerides (TG) and LDL-C in the PCOS + MS group (p < 0.05), but without dependency on HDL-C. Stepwise multiple linear regression analysis confirmed the different expression of oxidative stress in the three groups and decrease of SOD from control to PCOS group to PCOS + MS group, being associated with an increase of TG.

Conclusions

MS can accelerate the oxidative stress process in patients with PCOS and decrease the antioxidative capacity. The decreased antioxidant capacity in PCOS with MS is related to increased TG and LDL-C.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14:270–284CrossRef Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14:270–284CrossRef
2.
Zurück zum Zitat Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106:6–15CrossRef Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106:6–15CrossRef
3.
Zurück zum Zitat Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, International PCOS Network (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 110:364–379CrossRef Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, International PCOS Network (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 110:364–379CrossRef
4.
Zurück zum Zitat Ruan X, Song J, Gu M, Wang L, Wang H, Mueck AO (2018) Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients. Arch Gynecol Obstet 297:1557–1563CrossRef Ruan X, Song J, Gu M, Wang L, Wang H, Mueck AO (2018) Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients. Arch Gynecol Obstet 297:1557–1563CrossRef
5.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
6.
Zurück zum Zitat Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ (2015) Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA 313:1973–1974CrossRef Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ (2015) Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA 313:1973–1974CrossRef
7.
Zurück zum Zitat Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK (2011) Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care 34:1323–1328CrossRef Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK (2011) Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care 34:1323–1328CrossRef
8.
Zurück zum Zitat Kim HJ, Kim Y, Cho Y, Jun B, Oh KW (2014) Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998–2012. Int J Cardiol 174:64–72CrossRef Kim HJ, Kim Y, Cho Y, Jun B, Oh KW (2014) Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998–2012. Int J Cardiol 174:64–72CrossRef
9.
Zurück zum Zitat Prasad DS, Kabir Z, Dash AK, Das BC (2012) Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res 3:204–211CrossRef Prasad DS, Kabir Z, Dash AK, Das BC (2012) Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res 3:204–211CrossRef
10.
Zurück zum Zitat Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M (2014) Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol 30:397–402CrossRef Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M (2014) Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol 30:397–402CrossRef
11.
Zurück zum Zitat Moran LJ, Misso ML, Wild RA, Norman RJ (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16:347–363CrossRef Moran LJ, Misso ML, Wild RA, Norman RJ (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16:347–363CrossRef
12.
Zurück zum Zitat Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344CrossRef Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344CrossRef
13.
Zurück zum Zitat Murri M, Luque-Ramirez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19:268–288CrossRef Murri M, Luque-Ramirez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19:268–288CrossRef
14.
Zurück zum Zitat Insenser M, Montes-Nieto R, Murri M, Escobar-Morreale HF (2013) Proteomic and metabolomic approaches to the study of polycystic ovary syndrome. Mol Cell Endocrinol 370:65–77CrossRef Insenser M, Montes-Nieto R, Murri M, Escobar-Morreale HF (2013) Proteomic and metabolomic approaches to the study of polycystic ovary syndrome. Mol Cell Endocrinol 370:65–77CrossRef
15.
Zurück zum Zitat Papalou O, Victor VM, Diamanti-Kandarakis E (2016) Oxidative stress in polycystic ovary syndrome. Curr Pharm Des 22:2709–2722CrossRef Papalou O, Victor VM, Diamanti-Kandarakis E (2016) Oxidative stress in polycystic ovary syndrome. Curr Pharm Des 22:2709–2722CrossRef
16.
Zurück zum Zitat Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S, Witchel SF, Azziz R (2017) Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update 23:580–599CrossRef Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S, Witchel SF, Azziz R (2017) Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update 23:580–599CrossRef
17.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SCJ, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752CrossRef Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SCJ, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752CrossRef
18.
Zurück zum Zitat Rocha MP, Marcondes JAM, Barcellos CRG, Hayashida SAY, Curi DDG, da Fonseca AM, Bagnoli VR, Baracat EC (2011) Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol 27:814–819CrossRef Rocha MP, Marcondes JAM, Barcellos CRG, Hayashida SAY, Curi DDG, da Fonseca AM, Bagnoli VR, Baracat EC (2011) Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol 27:814–819CrossRef
19.
Zurück zum Zitat Ruan X, Li M, Mueck AO (2018) Why does Polycystic Ovary Syndrome (PCOS) need long-term management? Curr Pharm Des 24:4685–4692CrossRef Ruan X, Li M, Mueck AO (2018) Why does Polycystic Ovary Syndrome (PCOS) need long-term management? Curr Pharm Des 24:4685–4692CrossRef
20.
Zurück zum Zitat Mujica LS, Bridi A, Méa RD, Rissi VB, Guarda N, Moresco RN, Premaor MO, Antoniazzi AQ, Gonçalves PBD, Comim FV (2018) Oxidative stress and metabolic markers in pre- and postnatal polycystic ovary syndrome rat protocols. J Inflamm Res 11:193–202CrossRef Mujica LS, Bridi A, Méa RD, Rissi VB, Guarda N, Moresco RN, Premaor MO, Antoniazzi AQ, Gonçalves PBD, Comim FV (2018) Oxidative stress and metabolic markers in pre- and postnatal polycystic ovary syndrome rat protocols. J Inflamm Res 11:193–202CrossRef
21.
Zurück zum Zitat Gonzalez F, Rote NS, Minium J, Kirwan JP (2006) Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:336–340CrossRef Gonzalez F, Rote NS, Minium J, Kirwan JP (2006) Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:336–340CrossRef
22.
Zurück zum Zitat Seleem AK, El Refaeey AA, Shaalan D, Sherbiny Y, Badawy A (2014) Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet 31:499–504CrossRef Seleem AK, El Refaeey AA, Shaalan D, Sherbiny Y, Badawy A (2014) Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet 31:499–504CrossRef
23.
Zurück zum Zitat Moti M, Amini L, Mirhoseini Ardakani SS, Kamalzadeh S, Masoomikarimi M, Jafarisani M (2015) Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome. Iran J Reprod Med 13:373–378PubMedPubMedCentral Moti M, Amini L, Mirhoseini Ardakani SS, Kamalzadeh S, Masoomikarimi M, Jafarisani M (2015) Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome. Iran J Reprod Med 13:373–378PubMedPubMedCentral
24.
Zurück zum Zitat Rodrigues JK, Dib LA, Ferriani RA, Jordao Junior AA, Navarro PADA (2010) Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls. Rev Bras Ginecol Obstet 32:118–125CrossRef Rodrigues JK, Dib LA, Ferriani RA, Jordao Junior AA, Navarro PADA (2010) Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls. Rev Bras Ginecol Obstet 32:118–125CrossRef
25.
Zurück zum Zitat Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I (2012) Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome. J Endocrinol Invest 35:317–321PubMed Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I (2012) Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome. J Endocrinol Invest 35:317–321PubMed
26.
Zurück zum Zitat Stocker R, Keaney JFJ (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381–1478CrossRef Stocker R, Keaney JFJ (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381–1478CrossRef
27.
Zurück zum Zitat Sahaf B, Heydari K, Herzenberg LA, Herzenberg LA (2005) The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects. Arch Biochem Biophys 434:26–32CrossRef Sahaf B, Heydari K, Herzenberg LA, Herzenberg LA (2005) The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects. Arch Biochem Biophys 434:26–32CrossRef
28.
Zurück zum Zitat Vendemiale G, Guerrieri F, Grattagliano I, Didonna D, Muolo L, Altomare E (1995) Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration. Hepatology 21:1450–1454CrossRef Vendemiale G, Guerrieri F, Grattagliano I, Didonna D, Muolo L, Altomare E (1995) Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration. Hepatology 21:1450–1454CrossRef
29.
Zurück zum Zitat Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L, Fan P (2017) Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol 86:88–96CrossRef Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L, Fan P (2017) Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol 86:88–96CrossRef
30.
Zurück zum Zitat Zhang J, Zhang Y, Liu H, Bai H, Wang Y, Jiang C, Fan P (2015) Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil Steril 103:1346–1354CrossRef Zhang J, Zhang Y, Liu H, Bai H, Wang Y, Jiang C, Fan P (2015) Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil Steril 103:1346–1354CrossRef
31.
Zurück zum Zitat Morelli NR, Scavuzzi BM, Miglioranza LHDS, Lozovoy MAB, Simão ANC, Dichi I (2018) Metabolic syndrome components are associated with oxidative stress in overweight and obese patients. Arch Endocrinol Metab 62:309–318PubMed Morelli NR, Scavuzzi BM, Miglioranza LHDS, Lozovoy MAB, Simão ANC, Dichi I (2018) Metabolic syndrome components are associated with oxidative stress in overweight and obese patients. Arch Endocrinol Metab 62:309–318PubMed
32.
Zurück zum Zitat Macut D, BjekićMacut J, Savić-Radojević A (2013) Dyslipidemia and oxidative stress in pcos. Front Horm Res 40:51–63CrossRef Macut D, BjekićMacut J, Savić-Radojević A (2013) Dyslipidemia and oxidative stress in pcos. Front Horm Res 40:51–63CrossRef
Metadaten
Titel
Oxidative stress indicators in Chinese women with PCOS and correlation with features of metabolic syndrome and dependency on lipid patterns
verfasst von
Husheng Wang
Xiangyan Ruan
Yanglu Li
Jiaojiao Cheng
Alfred O. Mueck
Publikationsdatum
23.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2019
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-019-05305-7

Weitere Artikel der Ausgabe 5/2019

Archives of Gynecology and Obstetrics 5/2019 Zur Ausgabe

Gynecologic Endocrinology and Reproductive Medicine

When to do intracytoplasmic sperm injection: a prospective comparison

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.